Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
Cortese, Bernardo
Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study. [electronic resource] - Coronary artery disease Aug 2009 - 348-53 p. digital
Publication Type: Comparative Study; Journal Article
1473-5830
10.1097/MCA.0b013e32832cff08 doi
Acute Coronary Syndrome--drug therapy
Aged
Angioplasty, Balloon, Coronary--adverse effects
Anticoagulants--administration & dosage
Cardiovascular Diseases--etiology
Drug Administration Schedule
Drug Therapy, Combination
Female
Hemorrhage--etiology
Heparin--administration & dosage
Hirudins--administration & dosage
Humans
Infusions, Intravenous
Male
Middle Aged
Myocardial Infarction--etiology
Peptide Fragments--administration & dosage
Platelet Aggregation Inhibitors--administration & dosage
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Recombinant Proteins--administration & dosage
Retrospective Studies
Risk Assessment
Severity of Illness Index
Time Factors
Treatment Outcome
Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study. [electronic resource] - Coronary artery disease Aug 2009 - 348-53 p. digital
Publication Type: Comparative Study; Journal Article
1473-5830
10.1097/MCA.0b013e32832cff08 doi
Acute Coronary Syndrome--drug therapy
Aged
Angioplasty, Balloon, Coronary--adverse effects
Anticoagulants--administration & dosage
Cardiovascular Diseases--etiology
Drug Administration Schedule
Drug Therapy, Combination
Female
Hemorrhage--etiology
Heparin--administration & dosage
Hirudins--administration & dosage
Humans
Infusions, Intravenous
Male
Middle Aged
Myocardial Infarction--etiology
Peptide Fragments--administration & dosage
Platelet Aggregation Inhibitors--administration & dosage
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Recombinant Proteins--administration & dosage
Retrospective Studies
Risk Assessment
Severity of Illness Index
Time Factors
Treatment Outcome